These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37759755)
1. The Potential Mechanisms behind Loperamide-Induced Cardiac Arrhythmias Associated with Human Abuse and Extreme Overdose. Lu HR; Damiano BP; Kreir M; Rohrbacher J; van der Linde H; Saidov T; Teisman A; Gallacher DJ Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759755 [TBL] [Abstract][Full Text] [Related]
2. Characterization of loperamide-mediated block of hERG channels at physiological temperature and its proarrhythmia propensity. Sheng J; Tran PN; Li Z; Dutta S; Chang K; Colatsky T; Wu WW J Pharmacol Toxicol Methods; 2017; 88(Pt 2):109-122. PubMed ID: 28830713 [TBL] [Abstract][Full Text] [Related]
3. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic. Kang J; Compton DR; Vaz RJ; Rampe D Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870 [TBL] [Abstract][Full Text] [Related]
4. Revisiting the hERG safety margin after 20 years of routine hERG screening. Leishman DJ; Abernathy MM; Wang EB J Pharmacol Toxicol Methods; 2020 Sep; 105():106900. PubMed ID: 32768644 [TBL] [Abstract][Full Text] [Related]
5. Not your regular high: cardiac dysrhythmias caused by loperamide. Wightman RS; Hoffman RS; Howland MA; Rice B; Biary R; Lugassy D Clin Toxicol (Phila); 2016 Jun; 54(5):454-8. PubMed ID: 27022002 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin Causes a Novel Proarrhythmic Syndrome. Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648 [TBL] [Abstract][Full Text] [Related]
7. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR; Yan GX; Gallacher DJ J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247 [TBL] [Abstract][Full Text] [Related]
8. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse. Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687 [TBL] [Abstract][Full Text] [Related]
9. Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide. Klein MG; Haigney MCP; Mehler PS; Fatima N; Flagg TP; Krantz MJ JACC Clin Electrophysiol; 2016 Dec; 2(7):784-789. PubMed ID: 29759761 [TBL] [Abstract][Full Text] [Related]
10. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model. Lu HR; Gallacher DJ; Yan GX J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776 [TBL] [Abstract][Full Text] [Related]
11. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes? Lu HR; Hermans AN; Gallacher DJ Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168 [TBL] [Abstract][Full Text] [Related]
12. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model. Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Reinke F; Eckardt L; Frommeyer G Cardiovasc Toxicol; 2021 Mar; 21(3):248-254. PubMed ID: 33125619 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of physiological late Na El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840 [TBL] [Abstract][Full Text] [Related]
15. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents. Qiu B; Wang Y; Li C; Guo H; Xu Y J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655 [TBL] [Abstract][Full Text] [Related]
16. A Case Report of Torsade de Pointes and Brugada Pattern Associated with Loperamide Misuse and Supratherapeutic Loperamide Concentrations. Simon M; Rague J J Emerg Med; 2021 Oct; 61(4):e54-e59. PubMed ID: 34127340 [TBL] [Abstract][Full Text] [Related]
17. Risk of Cardiac Lesion with Chronic and Acute Use of Loperamide-An Integrative Review. Lammoglia BC; Hasselmann G; Pires-Oliveira M; Duarte Nicolau LA; Rolim Medeiros JV; Sabia Tallo F; Omar Taha M; Yamaguti Lima R; Caricati-Neto A; Menezes-Rodrigues FS J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547428 [TBL] [Abstract][Full Text] [Related]
18. Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative. Huang H; Pugsley MK; Fermini B; Curtis MJ; Koerner J; Accardi M; Authier S J Pharmacol Toxicol Methods; 2017 Sep; 87():11-23. PubMed ID: 28408211 [TBL] [Abstract][Full Text] [Related]
19. A Case Report of Loperamide-Induced Ventricular Storm. De Vera J; Kim HB; Sakr AE J Investig Med High Impact Case Rep; 2021; 9():2324709621990768. PubMed ID: 33533290 [TBL] [Abstract][Full Text] [Related]
20. ' Loperamide overdose induces ventricular tachycardia with catastrophic outcomes'. Ali Z; Shoukat U; Khan M; Roomi S; Ullah W J Community Hosp Intern Med Perspect; 2020 Jun; 10(3):229-232. PubMed ID: 32850070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]